Curexo Inc. (KOSDAQ:060280)
South Korea · Delayed Price · Currency is KRW 7,200.00
-120.00 (-1.64%)
Oct 23, 2026, 3:30 PM KST
Curexo Market Cap
Curexo has a market cap or net worth of 297.07 billion as of October 23, 2026. It is the 19,979th most valuable company in the world and the 625th biggest in South Korea. Its market cap has decreased by 37.35% in one year.
Market Cap
297.07B
Enterprise Value
271.86B
Revenue
77.74B
Global Rank
Country Rank
#625 South Korea
PE Ratio
54.14
ChartMarket Cap Chart
Since November 3, 2004, Curexo's market cap has increased from 3.98B to 297.07B, an increase of 7,359.40%. That is a compound annual growth rate of 21.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 297.07B | -44.21% |
| Dec 30, 2025 | 532.53B | 100.62% |
| Dec 30, 2024 | 265.44B | -65.17% |
| Dec 28, 2023 | 762.19B | 191.52% |
| Dec 29, 2022 | 261.46B | 5.49% |
| Dec 30, 2021 | 247.86B | 18.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| i-SENS | 469.59B |
| BioNote | 460.16B |
| T&L Co., Ltd. | 414.39B |
| WON TECH | 365.28B |
| Samyang Biopharm | 328.29B |
| ToolGen | 282.90B |
| Value Added Technology | 252.37B |
| Vieworks | 248.73B |